Kim N Chi Selected Research

Tablets

11/2019	Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
1/2018	Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim N Chi Research Topics

Disease

184	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 09/2003
76	Neoplasms (Cancer) 12/2023 - 09/2003
30	Neoplasm Metastasis (Metastasis) 12/2023 - 02/2009
23	Disease Progression 12/2023 - 01/2015
18	Pain (Aches) 12/2023 - 10/2004
14	Fatigue 12/2023 - 02/2008
8	Hypertension (High Blood Pressure) 01/2023 - 05/2011
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 02/2009
5	Urinary Bladder Neoplasms (Bladder Cancer) 03/2023 - 04/2010
5	Febrile Neutropenia 01/2023 - 08/2005
5	Exanthema (Rash) 01/2023 - 01/2019
5	Carcinoma (Carcinomatosis) 01/2020 - 08/2014
4	Neutropenia 01/2020 - 08/2005
4	Circulating Neoplastic Cells 12/2018 - 05/2015
3	Adenocarcinoma 01/2023 - 08/2012
3	Transitional Cell Carcinoma 02/2006 - 10/2002
2	Anemia 01/2023 - 01/2020
2	Sepsis (Septicemia) 01/2022 - 11/2017
2	Nausea 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 10/2021 - 01/2019
2	Seizures (Absence Seizure) 11/2019 - 09/2012
2	Lymphatic Metastasis 07/2017 - 09/2010
2	Hypokalemia 01/2017 - 05/2011
2	Fever (Fevers) 09/2010 - 02/2008
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2010 - 12/2005

Drug/Important Bio-Agent (IBA)

41	Docetaxel (Taxotere)FDA Link 03/2024 - 10/2004
39	AndrogensIBA 12/2023 - 02/2005
27	enzalutamideIBA 11/2023 - 09/2012
27	Abiraterone AcetateIBA 01/2023 - 05/2011
27	Prednisone (Sone)FDA LinkGeneric 01/2023 - 10/2004
26	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 06/2004
25	abirateroneIBA 11/2023 - 05/2011
23	Hormones (Hormone)IBA 04/2024 - 06/2004
17	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 12/2016
17	Biomarkers (Surrogate Marker)IBA 11/2022 - 08/2012
16	apalutamideIBA 04/2024 - 01/2019
13	Circulating Tumor DNAIBA 01/2023 - 11/2017
13	Cell-Free Nucleic AcidsIBA 11/2022 - 05/2015
12	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 10/2004
10	ClusterinIBA 01/2016 - 06/2004
9	OGX-011IBA 11/2017 - 09/2005
7	AntigensIBA 03/2024 - 12/2020
6	PlatinumIBA 11/2020 - 01/2016
5	olaparibIBA 11/2023 - 01/2020
5	bicalutamide (Casodex)FDA LinkGeneric 01/2023 - 08/2012
5	Testosterone (Sustanon)FDA Link 01/2023 - 01/2016
5	taxaneIBA 01/2023 - 01/2021
5	Antisense OligonucleotidesIBA 08/2013 - 06/2004
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2024 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2013
4	niraparibIBA 01/2023 - 01/2021
4	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2017
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 08/2014
4	PlacebosIBA 01/2020 - 01/2018
4	Alkaline PhosphataseIBA 10/2019 - 01/2016
3	177Lu-PSMA-617IBA 03/2024 - 01/2021
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2020
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
3	antiarrhythmic peptide (AAP)IBA 01/2023 - 01/2020
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 07/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 07/2005
3	RamucirumabIBA 01/2020 - 01/2016
3	Radium-223IBA 10/2019 - 09/2017
3	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019 - 10/2004
3	cabazitaxel FDA Link 10/2018 - 06/2015
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2018 - 05/2015
3	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 10/2002
3	Calcitriol (Calcijex)FDA LinkGeneric 01/2008 - 11/2006
2	Lutetium-177IBA 03/2024 - 01/2023
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
2	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 10/2021
2	hydrogen sulfite (bisulfite)IBA 01/2023 - 01/2020
2	ChromatinIBA 01/2023 - 11/2017
2	ipatasertibIBA 01/2023 - 10/2021
2	Androgen Antagonists (Antiandrogens)IBA 01/2023 - 08/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 01/2016
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	TabletsIBA 11/2019 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 10/2019 - 12/2009
2	cabozantinibIBA 01/2019 - 01/2016
2	Sunitinib (Sutent)FDA Link 12/2016 - 02/2009
2	MicroRNAs (MicroRNA)IBA 04/2013 - 08/2012
2	Phosphotransferases (Kinase)IBA 08/2012 - 06/2004
2	Gemcitabine FDA Link 04/2010 - 02/2006
2	Carboplatin (JM8)FDA LinkGeneric 04/2010 - 10/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 12/2009
2	VA 061 (VA061)IBA 06/2008 - 01/2008
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	Interleukin-4 (Interleukin 4)IBA 03/2024
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2023

Therapy/Procedure

141	Castration 03/2024 - 09/2008
80	Therapeutics 04/2024 - 06/2004
37	Drug Therapy (Chemotherapy) 01/2023 - 02/2005
6	Radiotherapy 03/2023 - 09/2003
5	Immunotherapy 01/2023 - 01/2015
4	Prostatectomy (Retropubic Prostatectomy) 05/2017 - 09/2005
3	Neoadjuvant Therapy 05/2017 - 12/2007
2	Aftercare (After-Treatment) 01/2023 - 01/2019
1	Investigational Therapies (Experimental Therapy) 11/2023